Frédérique Penault‐Llorca

Calibration of immunohistochemistry for assessment of HER2 in breast cancer: results of the French Multicentre GEFPICS* Study

Anne Vincent‐Salomon, Gaëtan MacGrogan, J Couturier et al. · Histopathology · 2003 · 121 citations

Medicine, Oncology, Pathology +17

Preclinical validation of AXL receptor as a target for antibody-based pancreatic cancer immunotherapy

Wilhem Leconet, Christel Larbouret, Thierry Chardès et al. · Oncogene · 2013 · 106 citations · Full text

Medicine, Cancer Biology, Oncology +14

Hsa-miR-31-3p Expression Is Linked to Progression-free Survival in Patients with KRAS Wild-type Metastatic Colorectal Cancer Treated with Anti-EGFR Therapy

Gilles Manceau, Sandrine Imbeaud, Raphaële Thiébaut et al. · Clinical Cancer Research · 2014 · 102 citations

Medicine, Oncology, Pathology +17

Panitumumab combined with irinotecan for patients with KRAS wild-type metastatic colorectal cancer refractory to standard chemotherapy: a GERCOR efficacy, tolerance, and translational molecular study

Thierry André, Hélène Blons, May Mabro et al. · Annals of Oncology · 2012 · 93 citations · Full text

Medicine, Oncology, Pharmacology +11

Delayed care for patients with newly diagnosed cancer due to COVID-19 and estimated impact on cancer mortality in France

Jean‐Yves Blay, Sophie Boucher, Béatrice Le Vu et al. · ESMO Open · 2021 · 80 citations · Full text

Medicine, Oncology, Cancer Control +16